Marcelo Larramendy
Overview
Explore the profile of Marcelo Larramendy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
54
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Collins A, Moller P, Gajski G, Vodenkova S, Abdulwahed A, Anderson D, et al.
Nat Protoc
. 2023 Jan;
18(3):929-989.
PMID: 36707722
The comet assay is a versatile method to detect nuclear DNA damage in individual eukaryotic cells, from yeast to human. The types of damage detected encompass DNA strand breaks and...
2.
Curieses S, Saenz M, Larramendy M, Di Marzio W
Ecotoxicology
. 2016 Apr;
25(5):914-23.
PMID: 27030125
The management and final disposal of industrial wastes are a matter of considerable human concern. The present study evaluates the cyto/genotoxic effects and changes of the coelomic cell formulas exerted...
3.
Olivero O, Larramendy M, Soloneski S, Menck C, Matta J, Folle G, et al.
Environ Mol Mutagen
. 2010 Mar;
51(8-9):763-73.
PMID: 20213840
This collection of articles was inspired by the long-standing relationship between the Environmental Mutagen Society and Latin American scientists, and by the program for the 39th Environmental Mutagen Society meeting...
4.
Karol E, Karol B, Larramendy M
Neurol Res
. 2005 Sep;
27(6):571-9.
PMID: 16157005
Objectives: An original method and technique was designed to reduce the still significant morbidity of percutaneous thermocoagulation in the treatment of trigeminal neuralgia. A critical part of this technique is...
5.
Brandal P, Micci F, Bjerkehagen B, Eknaes M, Larramendy M, Lothe R, et al.
Cancer Genet Cytogenet
. 2003 Sep;
146(1):1-7.
PMID: 14499689
Desmoid tumors are benign neoplasms of the fibromatosis group. Data on their acquired chromosomal changes are sparse and, therefore, we wanted to ascertain what genomic losses and gains these tumors...